1999/2000 Publications Page |
1999/2000 Publications Page |
1. Anderson TJ, Elstein E, Haber H, Charbonneau F: Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease. J Am Coll Cardiol. 35:60-6, 2000.
2. Augoustides-Savvopoulou P, Mylonas I, Sewell AC and Rosenblatt DS: Reversble dementia in an adolescent with cblC disease: Clinical heterogeneity within the same family. J Inher Metab Dis 22:756-758, 1999.
3. Bibi H, Gelman-Kohan Z, Baumgartner ER and Rosenblatt DS: Transcobalamin II deficiency with methylmalonic aciduria in three sisters. J Inher Metab Dis 22:765-772, 1999.
4. Blumen SC, Brais B, Korczyn AD, Medinsky S, Chapman J, Asherov A, Nisipeanu P, Codere F, Bouchard JP, Fardeau M, Tome FM, Rouleau GA: Homozygotes for Oculopharyngeal Muscular Dystrophy have a Severe form of the Disease. Annals of Neurology 46:115-118, 1999.
5. Bourgault C, Suissa S, Elstein E , Lelorier J: Reference based pricing of pharmaceuticals: Assessing therapeutic equivalence of ACE inhibitors. CMAJ 161: 255-260, 1999.
6. Brais B, Rouleau GA, Bouchard J-P, Fardeau M, Tomé FMS: Oculopharyngeal Muscular Dystrophy. Seminars in Neurology 19:59-66, 1999.
7. Brooks-Wilson A, Marcil M, Clee SM, Zhang L-H, Roomp K, van Dam M, Yu L, Brewer C, Collins JA, Molhuizen HOF, Loubser O, Ouelette BFF, Fichter K, Ashbourne-Excoffon KJD, Sensen CW, Scherer S, Mott S, Denis M, Martindale D, Frohlich J, Morgan K, Koop B, Pimstone S, Kastelein JJP, Genest Jr. J, Hayden MR: Mutations in the ATP binding cassette (ABC1) transporter gene in Tangier disease and familial HDL deficiency (FHA). Nature Genetics 22:336-345, 1999.
8. Camu W, Khoris J, Moulard B, Salachas F, Briolotti V, Rouleau GA, Meininger V: Genetics of familial ALS and consequences for diagnosis. French ALS Research Group. Journal of Neurological Sciences 165 Suppl 1:S21-6, 1999.
9. Cantarovich M, de Gruchy S, Forbes C, Marpole D, Elstein E, Magnan C, de Varennes B: Optimal timing for surveillance endomyocardial biopsies in heart transplant patients reveiving antithymocyte globulin induction. Transplant Proc. 31:79, 1999.
10. Cantarovich M, Elstein E, de Varennes B, Barkun S. Clinical benefit of Neoral dose monitoring with cyclosporine 2-hr post dose levels compared with trough levels in stable heart transplant patients. Transplantation 68:1839-1842, 1999.
11. Cantarovich M, Quantz M, Elstein E, Ergina P, Magnan C,de Varennes B. Neoral dose monitoring with cyclosporine 2-hour postdose levels in heart transplant patients receiving anti-thymocyte globulin induction. Transplant Proc.32:446-448, 2000.
12. Christensen B, Arbour L, Tran P, Leclerc D, Sabbaghian N, Platt R, Gilfix BM, Rosenblatt DS, Gravel RA, Forbes P, Rozen R: Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. Am J Med Genet 84:151-157,1999.
13. Dichgans M, Schols L, Herzog J, Stevanin G, Weirich-Schwaiger H, Rouleau G, Burk K, Klockgether T, Zuhlke C, Laccone F, Riess O, Gasser T. Spinocerebellar Ataxia type 6: evidence for a strong Founder Effect among German families. Neurology 52:849-51, 1999.
14. Elstein E, Huan C, Fitchett D, Cantarovich M, Marpole D. C677T gene mutation in methylenetetrahydrofolate reductase as a risk factor for cardiac allograft vasculopathy. Transplant Proc. 31:99, 1999.
15. Engert JC, Doré C, Mercier J, Ge B, Bétard C, Rioux JD, Owen C, Bérubé P, Devon K, Birren B, Melançon SB, Morgan K, Hudson TJ, Richter A: Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS): High-resolution physical and transcript map of the candidate region in chromosome region 13q11. Genomics 62:156-164, 1999.
16. Enns GM, Barkovich AJ, Rosenblatt DS, Fredrick DR, Weisiger K, Ohnstad C, Packman S: Progressive neurological deterioration and MRI changes in cblC methylmalonic acidaemia treated with hydroxocobalamin. J Inher Metab Dis 22:599, 1999.
17. Gaudet D, Arsenault S, Bélanger C, Hudson TJ, Perron P, Bernard M, Hamet P: Procedure to protect confidentiality of familial data in community genetics and genomic research. Clin. Genet. 55:259-264
18. Goobie S, Morrison J, Ginzberg H, Ellis L, Corey M, Masuno M, Imaizumi K, Kuroki Y, Fujiwara TM, Morgan K, Durie PR, Rommens JM: Exclusion of linkage of Shwachman-Diamond syndrome to chromosome regions 6q and 12q
19. Greenwood CTM, Brewer CG, Morgan K: Validation of linkage by sampling based on environmental exposures. In: Goldin L, Amos CI, Chase GA, Goldstein AM, Jarvik GP, Martinez MM, Suarez BK, Weeks DE, Wijsman EM, MacCluer JW. Genetic Analysis Workshop 11: Analysis of genetic and environmental factors in common diseases. Genetic Epidemiology 17(1):S593-S598, 1999. implicated by a de novo translocation. American Journal of Medical Genetics 85:171-174, 1999.
20. Hukriede NA, Joly L, Tsang M, Miles J, Tellis P, Epstein JA, Barbazuk WB, Li FN, Paw B, Postlethwait JH, Hudson TJ, Zon LI, McPherson JD, Chevrette M, Dawid IB, Johnson SL, Ekker M: Radiation hybrid mapping of the zebrafish genome. Proc Natl. Acad. Sci. USA 96:9745-9750, 1999.
21. Israels SJ, Gilfix BM: Alphal-antitrypsin deficiency presenting with fatal intracranial hemorrhage in a newborn. J Pediatric Hematology/Oncology 21(5):447-450, 1999.
22. Jernström H, Lerman C, Ghadirian P, Lynch H, Weber B, Garber J, Daly M, Olopade O, Foulkes WD, Warner E, Brunet J-S, Narod SA: Pregnancy increases the risk of early breast cancer in BRCA1 and BRCA2 carriers. Lancet 354:1846-1850, 1999.
23. Joober R, Benkelfat C, Toulouse A, Lafrenière RGA, Lal S, Ajroud S, Turecki G, Bloom D, Labelle A, Lalonde P, Alda M, Morgan K, Palmour R, Rouleau GA: Analysis of 14 CAG repeat-containing genes in schizophrenia. American Journal of Medical Genetics 88:694-699, 1999.
24. Joober R, Benkelfat C, Brisebois K, Toulouse A, Lafreniere R, Turecki G, Lal S, Bloom D, Labelle A, Lalonde P, Fortin D, Alda M, Palmour R, Rouleau GA: Lack of Association Between the hSKCa3 Channel Gene CAG Polymorphism and Schizophrenia. Neuropsychiatric Genetics 88:154-157, 1999.
25. Joober R, Benkelfat C, Brisebois K, Toulouse A, Turecki G, Lal S, Bloom D, Labelle A, Lalonde P, Fortin D, Alda M, Palmour R, Rouleau GA: T102C polymorphism in the 5HT2A gene and schizophrenia: relation to phenotype and drug response variability. Journal of Psychiatry and Neuroscience 24:141-146 1999.
26. Joober R, Benkelfat C, Jannatipour M, Turecki G, Lal S, Mandel J, Bloom D, Lalonde P, Lopes-Cendes I, Fortin D, Rouleau GA: Polyglutamine-containing proteins in schizophrenia. Molecular Psychiatry 1999; 4:53-57, 1999.
27. Kasprzak L, Foulkes WD, Shelling AN: Hereditary ovarian carcinoma.Clinical Review. British Medical Journal 318:786-789, 1999.
28. Kibar Z, Lafreniere R, Chakravarti A, Wang J, Chevrette M, Der Kaloustian V, Rouleau GA: A Radiation Hybrid Map of 48 Loci Including the Clouston Hidrotic Ectodermal Dysplasia (HED) Locus in the Pericentromeric Region of Chromosome 13q. Genomics 56:127-130, 1999.
29. Korenberg JR, Chen X-N, Sun Z, Shi Z-Y, Ma S, Vataru E, Yimlamai D, Weissenbach JS, Shizuya H, Simon MI, Gerety SS, Nguyen H, Zemsteva IS, Hui L, Silva J, Wu X, Birren BW, Hudson TJ: Human genome anatomy: BACs integrating the genetic and cytogenetic maps for bridging genome and biomedicine. Genome Research 9:994-1001 16.
30. Larson GP, Ding S, Lafrenière RG, Rouleau GA, Krontiris TG: Instability of the EPM1 minisatelitte. Human Molecular Genetics 8:1985-1988, 1999
31. Maciel P, Gaspar C, Guimaraes L, Goto J, Lopes-Cendes I, Hayes S, Arvidsson K, Dias A, Sequerios J, Sousa A, Rouleau GA: Study of Three Intragenic Polymorphisms in the Machado-Joseph Disease Gene (MJD1) in Relation to Genetic Instability of the (CAG)n Tract. European Journal of Human Genetics 7:147-156, 1999.
32. Mackay D, Ionides A, Kibar Z, Rouleau GA, Berryl V, Moore A, Shiels A, Bhattacharya S: Connexin-46 mutations in autosomal dominant congenital cataract. American Journal of Human Genetics 64:1357-1364, 1999.
33. Manning A, Mes-Masson A-M, Seymour RJ, Tetrault M, Provencher D, Tonin PN: Expression of FHIT in primary cultures of human epithelial ovarian tumours and malignant ascites. Molec Carcinogen 24:218-225, 1999.
34. Mezei M, Mankodi A, Brais B, Marineau C, Thornton C, Rouleau GA, Karpati G: Subclinical (GCG) Trinucleotide Expansion in the PABP2 Gene is Not a Predisposing Genetic Factor for Sporadic Inclusion Body Myositis. Neurology 52:669-670, 1999.
35. Nusbaum C, Slonim DK, Harris KL, Birren BW, Steen RG, Stein LD, Miller J, Dietrich WF, Nahf R, Wang V, Merport O, Castle AB, Husain Z, Farino G, Gray D, Anderson MO, Devine R, Horton Jr. LT, Ye W, Wu X, Kouyoumjian V, Zemsteva IS, Wu Y, Collymore AJ, Courtney DF, Tam J, Cadman M, Haynes AR, Heuston C, Marsland T, Southwell A, Trickett P, Strivens MA, Ross MT, Makalowski W, Xu Y, Boguski MS, Carter NP, Denny P, Brown SMD, Hudson TJ, Lander ES: A YAC-based physical map of the mouse genome. Nature Genetics 22:388-393, 1999.
36. Parboosingh JS, Meininger V, McKenna-Yasek D, Brown RH, Rouleau GA: Deletions causing spinal muscular atrophy do not predispose to amyotrophic lateral sclerosis. Archives of Neurology 56:710-712, 1999.
37. Pardo-Manuel de Villena F, de la Casa-Esperon E, Verner A, Morgan K, Sapienza C: The maternal DDK syndrome phenotype is determined by modifier genes that are not linked to Om. Mammalian Genome 10(5):492-497, 1999.
38. Pereira P, Stanton V, Jothy S, Tomlinson IPM, Foulkes WD, Rozen R: Loss of heterozygosity of methylenetetrahydrofolate reductase in colon carcinomas. Oncology Reports 6:597-599, 1999.
39. Richter A, Rioux J, Bouchard J-P, Mercier J, Mathieu J, Ge B, Poirier J, Julien D, Gyapay G, Weissenbach J, Hudson TJ, Melançon SB, Morgan K: Location score and haplotype analyses of the locus for autosomal recessive spastic ataxia of Charlevoix-Saguenay, in chromosome region 13q11. American Journal of Human Genetics 64:768-775, erratum ib. p. 1257, 1999.
40. Sniderman LC, Lambert M, Giguère R, Auray-Blais C, Lemieux Laframboise R, Rosenblatt DS and Treacy EP: Outcome of individuals with low-moderate methylmalonic aciduria detected through a neonatal screening program. J. Pediatr. 134(6):675-680, 1999.
41. Tonin PN: Breast Cancer Linkage Consortium; Carriers risks in BRCA2 mutation carriers. J Natl Cancer Instit 91:1310-1316, 1999.
42. Tonin PN, Mes-Masson A-M, Narod S, Ghadirian P, Provencher D: Founder BRCA1 and BRCA2 mutations in French Canadian ovarian cancer cases unselected for family history. Clinical Genet 55:318-324, 1999
43. Turecki G, Alda M, Grof P, Cavazzoni P, Duffy A, Grof E, Ahrens B, Berghöfer A, Müller-Oerlinghausen B, Dvoráková M, Libigerová E, Vojtechovský M, Zvolský P, Joober R, Nilsson A, Prochazka H, Licht RW, Rasmussen NA, Schou M, Vestergaard P, Holzinger A, Schumann C, Thau K, Rouleau GA: Expanded Polyglutamine tracts: No evidence of a major role in bipolar disorder. Molecular Psychiatry 4:220-221, 1999.
44. Turecki G, Brière R, Dewar K, Antonetti T, Lesage A, Séguin M, Chawky N, Alda M, Joober R, Benkelfat C, Rouleau GA: Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide. American Journal of Psychiatry 156:1456-1458, 1999.
45. Turecki G, Grof P, Cavazzoni P, Duffy A, Grof E, Ahrens B, Berghöfer A, Müller-Oerlinghausen B, Dvoráková M, Libigerová E, Vojtechovský M, Zvolský P, Joober R, Nilsson A, Prochazka H, Licht RW, Rasmussen NA, Schou M, Vestergaard P, Holzinger A, Schumann C, Thau K, Rouleau GA, Alda M : MAOA: Association and linkage studies in lithium responsive bipolar disorder. Psychiatric Genetics 9:13-16, 1999.
46. Van Etten WJ, Steen RG, Nguyen H, Castle AB, Slonim DK, Ge B, Nusbaum C, Schuler GD, Lander ES, Hudson TJ: Radiation hybrid map of the mouse genome. Nature Genetics 22 : 384-387, 1999.
47. Wang Z-J, Churchman M, Campbell IG, Xu W-H, Yan Z-Y, McCluggage WG, Foulkes WD Tomlinson IPM: Allele loss and mutation screen at the Peutz-Jeghers (LKB1) locus (19p13.3) in sporadic ovarian tumours. Br J Cancer 80:70-72, 1999.
48. Warner E, Foulkes WD, Goodwin P, Meschino W, Blondal J, Patterson C, Ozcelik H, Goss P, Allingham-Hawkins D, Hamel N, Di Prospero L, Contiga V, Serruya C, Klein M, Moslehi R, Honeyford J, Liede A, Glendon G, Brunet J-S, Narod S: Prevalence and penetrance of BRCA1 and BRCA2 mutations in unselected Ashkenazi Jewish women with breast cancer. J Natl Cancer Instit 91:1241-1247, 1999.
49. Wilson A, Leclerc D, Rosenblatt DS and Gravel RA: Molecular basis for methionine synthase reductase deficiency in patients belonging to the cblE complementation group of disorders in folate/cobalamin metabolism. Hum Molec Genet 8:2009-2016, 1999.
50. Xiong L, Labuda M, Li D-S, Hudson TJ, Desbiens R, Patry G, Verret S, Langevin P, Mercho S, Seni M-H, Scheffer I, Dubeau F, Berkovic SF, Andermann F, Andermann E, Pandolfo M: Mapping of a gene determining familial partial epilepsy with variable foci to chromosome 22q11-q12. Am. J. Hum. Genetics, 65 :1698-1710, 1999.
51. Yuan ZQ, Bégin LR, Wong N, Brunet J-S, Trifiro M, Gordon PH, Pinsky L, Foulkes WD: The effect of the I1307K APC polymorphism on the clinicopathological features and natural history of breast cancer. Br J cancer 81:850-854, 1999.
1. Rezvani I and Rosenblatt DS: An Approach to Inborn Errors of Metabolism, in Nelson Text Book of Pediatrics (16th ed), W.E. Nelson, R.E. Behrman, R.M. Kliegman and A.M. Arvin (eds.) W.B. Saunders Company, Philadelphia, 1999, Chapter 81 pp 343-344.
2. Rezvani I and Rosenblatt DS: Defects in Metabolism of Amino Acids, in Nelson Text Book of Pediatrics (16th ed), W.E. Nelson, R.E. Behrman, R.M. Kliegman and A.M. Arvin (eds.) W.B. Saunders Company, Philadelphia, 1999, Chapter 82.6 pp 354-362.
3. Rosenblatt DS and Fenton WA: Inborn Errors of Cobalamin Metabolism, in Chemistry and Biochemistry of of B12, R. Banerjee (ed) John Wiley & Sons, Inc., New York, 1999, pp 367-384.
4. Rosenblatt DS and Hoffbrand AV: Megaloblastic anemia and disorders of cobalamin and folate metabolism, in Pediatric Hematology. J. Lilleyman, I. Hann, V. Blanchette, (eds.) 2nd edition, Churchill Livingstone, 1999, pp 167-184.
5. Rosenblatt DS and Whitehead VM: Cobalamin and folate deficiency in children: Acquired and hereditary disorders, in Seminars in Hematology. P.A. Miescher, E.R.Jaffé (eds.) W.B. Saunders Co. 36:19-34, 1999.
1. Arthus MF, Lonergan M, Crumley J, Naumova AK, Morin D, De Marco LA, Kaplan BS, Robertson GL, Sasaki S, Morgan K, Bichet DG, Fujiwara TM: Origin of AVPR2 mutations in 117 families with X-linked nephrogenic diabetes insipidus. (Poster at the Annual Meeting of the American Society of Nephrology, 1-8 November 1999, Miami Beach) Journal of the American Society of Nephrology 10(Program and Abstracts Issue):430A, #A2170, 1999.
2. Bolduc N, Bielanska MM, Tan SL, Ao A, Désilets V: Normal twin pregnancy following ICSI of ejaculate spermatozoa from a patient with Klinefelter's syndrome. Am J Hum Genet 65:A945, 1999.
3. Brooks-Wilson A, Genest Jr. JJ, van Dam MJ, Marcil M, Brewer C, Mott S, Morgan K, Hayden MR, Kastelein JJP: Alletic but not genetic heterogeneity underlies Tangier disease. (Slide presentation at the 72 Scientific Sessions of the American Heart Association, 7-10 November 1999, Atlanta) Circulation 100(l):I-198, #1022, 1999.
4. Brooks-Wilson A, Marcil M, Clee SM, Zhang LH, Roomp K, van Dam M, Yu L, Brewer C, Collins JA, Molhuizen HOF, Ouellette BFF, Sensen CW, Martindale D, Frohlich J, Morgan K, Koop B, Pimstone S, Kastelein JJP, Genest Jr. J, Hayden MR: Mutations in transportin (ABC1) in Tangier disease and familial HDL deficiency. (Slide presentation at the Annual Meeting of the American Society of Human Genetics, 19-23 October 1999, San Francisco) Amer J Hum Genet 65(l):A34, #173, 1999.
5. Cantarovich M, Barkun J, Hirsh A, Carroll P, Elstein E, Ergina P, de Varennes B. Predictors of long-term renal function after heart transplantation. Transplantation 1999; 67(7):S108.
6. Cantarovich M, Elstein E, Magnan C, Chartier R, Blondeau J, de Varennes B. Clinical benefit of Neoral dose monitoring with cyclosporine 2-hr post-dose levels compared to trough levels in stable heart transplant patients. Transplantation 1999;67(7):S24.
7. Cartier L, Patenaude Y, Montes JL, Sinsky A, Désilets V: Prenatal diagnosis of an extracranial vascular lesion. J Ultrasound Med 19:S110, 2000.
8. Der Kaloustian VM, Davignon J, McCuiag C, Gilfix BM, Babineau T, Moroz B, Roman JP, Melançon S: A new disorder or a variant form of Chanarin-Dorfman syndrome in two sisters. American Society Of Human Genetics. 49th Annual Scientific Meeting October 20-24, Am J Hum Gene 65(4):A147, 1999.
9. Dombrowski C, Morel ML, Lévesque S, Morgan K, Rousseau F: Génétique des populations du syndrome X-fragile. Journées Scientifiques de l'IREP, Centre de recherche du Centre hospitalier de l'Université de Montréal, Montréal, 8 & 9 February 1999, Programme p. 33
10. Elstein E, Fagih B, Page S, Gilfix BM: Determinants of homocysteine in heart transplant patients. American Society of Transplantation. 18th Annual Scientific Meeting May 15-19, Transplantation 67(7):S106, 1999.
11. Engert JC, Doré C, Mercier J, Bérubé P, Lepage P, Ge B, Morgan K, Hudson TJ, Richter A: High resolution physical and transcript mapping of the critical interval for the ARSACS gene identifies two candidate genes. (Poster at the Annual Meeting of the American Society of Human Genetics, 19-23 October 1999, San Francisco) American Journal of Human Genetics 65(l):A225, #1247, 1999.
12. Gilfix BM, Cantarovich M, Elstein E: Relationship between cyclosporine, creatinine, and homocysteine in cardiac transplant patients. American Society of Transplantation. 18th Annual Scientific Meeting May 15-19, Transplantation 67(7):S106, 1999.
13. Gowans G, Cartier L, Jutras L Fouron JC, Désilets V: Frequency of congenital heart defects detected by fetal echocardiography in fetuses with increased nuchal thickness and normal karyotypes. J Ultrasound Med 19:S110, 2000.
14. Hudson TJ, Mata S, Bétard C, Brewer CG, Ge B, Clark SL, Lei M, Frappier D, Hudson N, Kassis J, Rauch J, Busque L, Ferland D, Fujiwara TM, Morgan K, Fortin P: Presence of abnormally high frequency of autoantibodies: a challenging complex trait. Evidence for linkage to chromosome 1q and HLA regions. Fifth Canadian Connective Tissue Conference, Montreal, 28-29 May 1999.
15. Jones AO, Tzenova J, Fujiwara TM, Frappier D, Tieder M, Morgan K, Tenenhouse HS:. NPT2 is not the gene responsible for hereditary hypophosphatemic rickets with hypercalciuria (HHRH) in a Bedouin kindred. (Poster at the Annual Meeting of the American Society of Nephrology, 1-8 November 1999, Miami Beach) Journal of the American Society of Nephrology 10(Program and Abstracts Issue):435A, #A2197, 1999.
16. Kasprzak L, Nolet S, Gaboury L, Gregory W, Pavia C, Villabona C, Rivera-Fillat Fca, Oriola J, Foulkes WD: Familial medullary thyroid carcinoma and prominent corneal nerves associated with a codon 804 germline mutation of the RET gene. 49th Annual Meeting of the American Society of Human Genetics. October 19-23, 706:A132, 1999.
17. Lambert D, Graham GE, Rozen R, Gilfix BM, Seni H, Andermann E, Treacy EP: Influence of VPA and CBZ monotherapy on homocysteine metabolism and copper levels in premenopausal epileptic women. American Society Of Human Genetics. 49th Annual Scientific Meeting October 20-24, Am J Hum Gene 65(4):A180, 1999.
18. Laprise C, Murphy J, Brewer C, Morgan K, Ouhna K, Vézina H, Hudson TJ: Analyse génétique de l'asthme au Saguenay-Lac-St-Jean. Journées Scientifiques de l'IREP, Centre de recherche du Centre hospitalier de l'Université de Montréal, Montréal, 8 & 9 February 1999, Programme p. 29 9.
19. Lévesque S, Morel ML, Dombrowski C, Morgan K, Rousseau F: Transmission et instabilité des allèles FMR1 dans la population générale. Journées Scientifiques de l'IREP, Centre de recherche du Centre hospitalier de l'Université de Montréal, Montréal, 8 & 9 February 1999 Programme p. 34, 17. Tonin PN, Serruya C, Jananji S, Morgan K, Tulandi T: Familial risk of endometriosis: an evaluation of the family history of 98 cases of endometriosis from two tertiary hospitals in Montreal recruited through fertility clinics. (Poster at Conjoint Annual Meeting of the American Society for Reproductive Medicine and The Canadian Fertility and Andrology Society, 25-30 September 1999, Toronto) Fertility and Sterility 72(1):S174, # P-263, 1999.
20. Wang XL, Solymoss S, Gilfix BM: Screening for the Factor V Leiden mutation using Activated Protein C Resistance Ratio. Society For Inherited Metabolic Disorders. Annual Meeting March 12-15, 1999.
21. Weiler T, Sudha T, Nylen E, Fujiwara TM, Morgan K, Greenberg CR, Wrogemann K: Refinement of the limb girdle muscular dystrophy type 2H (LGMD2H) candidate region. (Poster at the Annual Meeting of the American Society of Human Genetics, 19-23 October 1999, San Francisco) Amer J Hum Genet 65(l):A452, #2567, 1999.
1. Foulkes WD, Brunet J-S, Warner E, Goodwin P, Meschino W, Narod SA, Goss PE, Glendon G: The importance of a family history of breast cancer in predicting the presence of a BRCA mutation. AM. J. Hum. Genet. 65: 1776-1779, 1999. (Letter)
2. Hamel N, Manning A, Black MJ, Tonin PN, Foulkes WD: An absence of founder BRCA2 mutations in individuals with squamous cell carcinoma of the head and neck. Int. J. Cancer (Pred. Oncol) 83: 803-804, 1999. (Letter)
3. Rosenblatt DS: Folate and homocysteine metabolism and gene polymorphism in the etiology of Down Syndrome. Am. J. Clin. Nutr. 70 (4):429-430, 1999 (Editorial).
4. Rosenblatt DS: Genetics Disorders of Human Sexual Development by L. Pinsky, R.P Erickson, and R.N. Schimke, Oxford University Press Canada, 1999, 392 pages. (Book Review).
5. Rosenblatt DS: Is homocysteine the New Cholesterol? LayMedix 6 (2):4, 1999. (Editorial)
6. Yuan ZQ, Wong N, Foulkes WD, Trifiro M, Alpert L, Manganaro F, Andreutti-Zaugg C, Iggo R, Pinsky L, Gordon P, Lasko D: A missense mutation in both hMSH2 and APC in an HNPCC kindred: implications for clinical screening. J. Med. Genet. 36: 790-792, 1999. (Letter)
(c)2000 Finestone Labloratory
